Literature DB >> 23040556

Nonarthroplasty options for the management of massive and irreparable rotator cuff tears.

Ruth A Delaney1, Albert Lin, Jon J P Warner.   

Abstract

Massive, irreparable rotator cuff tears remain a clinical challenge. In low-demand patients, debridement of the tear may relieve pain. Partial repair using the technique of margin convergence decreases the size of the tear gap and reduces strain. Biceps tenotomy or tenodesis has a role in providing pain relief in massive rotator cuff tears. Tendon transfers offer good results in patients with massive, irreparable rotator cuff tears. The treatment modality specifically chosen for the massive, irreparable rotator cuff tear must be tailored to the individual patient, their needs and expectations, and their ability to comply with intensive rehabilitation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040556     DOI: 10.1016/j.csm.2012.07.008

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  4 in total

1.  Fluoroscopy-guided implantation of subacromial "biodegradable spacer" using local anesthesia in patients with irreparable rotator cuff tear.

Authors:  Enrico Gervasi; Enrico Cautero; Assaf Dekel
Journal:  Arthrosc Tech       Date:  2014-07-21

Review 2.  No prosthetic management of massive and irreparable rotator cuff tears.

Authors:  Alessandro Castagna; Raffaele Garofalo; Eugenio Cesari
Journal:  Shoulder Elbow       Date:  2014-06-17

3.  Clinical and radiological outcomes after reverse shoulder arthroplasty in patients with failed deltoid or latissimus dorsi transfers. A review of ten cases.

Authors:  Philippe Valenti; Ali Maqdes; Jean-David Werthel
Journal:  Int Orthop       Date:  2017-06-01       Impact factor: 3.075

4.  The use of a synthetic shoulder patch for large and massive rotator cuff tears - a feasibility study.

Authors:  P Cowling; R Hackney; B Dube; A J Grainger; J D Biglands; M Stanley; D Song; P G Conaghan; S R Kingsbury
Journal:  BMC Musculoskelet Disord       Date:  2020-04-07       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.